Zydus Lifesciences Appoints Christoph Stoller as President, Int'l Markets

Zydus Lifesciences Ltd has announced changes in its senior management team. Dr. Amrut Naik has resigned as President and Business Unit Head, International Markets Business, with his last day being November 7, 2026. Concurrently, the company has appointed Mr. Christoph Stoller to the same position, effective November 2, 2026. Mr. Stoller brings over 30 years of global pharmaceutical industry experience, including leadership roles at Glenmark Pharmaceuticals and Teva Pharmaceuticals. His appointment is expected to bolster the company's international market strategies.